Yesterday the Nepal Journal of Epidemiology published our editorial on ‘Strengthening Healthcare through Academic and Industry Partnership Research’ [1]. The editors put the editorial on the cover of the latest issue of the journal. Academic and Industry Partnership Research can drive medical innovation, strengthen patient-centred research, and close the gap between theoretical understanding and real-world implementations. The UK’s dedication to developing long-term alliances based on mutual respect and open dialogue can facilitate an environment where ground-breaking research can flourish and be transformed into affordable health and social care solutions.Half of the authors are associated with Bournemouth University, two are Visiting Faculty (Prof. Dr. Padam Simkhada and Dr. Brijesh Sathian) and the third one is Prof. Edwin van Teijlingen in the Centre for Midwifery & Women’s Health (CMWH). The Nepal Journal of Epidemiology is an Open Access journal and therefore the paper is freely available to read to anyone across the globe.
References:
- Sathian, B., van Teijlingen, E. ., Simkhada, P., Banerjee, I., Manikyam, H. K., & Kabir, R. (2023). Strengthening Healthcare through Academic and Industry Partnership Research. Nepal Journal of Epidemiology, 13(2), 1264–1267. https://doi.org/10.3126/nje.v13i2.58243
Congratulations to Prof. Bouchachia on latest paper
Last BU paper of 2022
The difference between two editorials
New paper on federalisation of health system in Nepal
BU academic publishes in online newspaper in Nepal
Final day of the ESRC Festival of Social Science
Using Art to enhance Research
Register now to attend the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease